期刊文献+

继发性高促性腺激素闭经的病因与临床表现的异质性——附245例病历分析

Heterogeneity of clinical feature and etiology of secondary hypergonadotropic amenorrhea with clinical analysis of 245 cases
下载PDF
导出
摘要 目的探讨继发性高促性腺激素闭经(SHA)的病因与表现的异质性(多样性)以及治疗对策。方法回顾性分析245例SHA病历,电话或通信随访到71例,描述其病史、症状、体格检查、实验室、影像学、腹腔镜及骨密度检查指标、治疗和随诊情况。结果病因可能涉及遗传、免疫、手术、放疗、化疗、免疫抑制治疗等医源性因素以及受感染、环境和心理等影响。闭经之前月经形式多种多样,闭经之后7例患者一度恢复自然月经,甚至妊娠。72.7%的患者呈低骨量。结论SHA从病因、病程到临床表现都有明显的多样性,对SHA不要放弃促生育的努力,还应关注其低骨量等健康问题。 Objective: To investigate the heterogeneity of clinical feature and etiology in patients with secondary hypergonadotropic amenorrhea (SHA) . Methods: 245 cases of SHA were retrospectively analyzed and 71 cases have been followed by phone or letter to describe the history, symptoms, medical examination, laboratory and imaging examination, laparoscopy, bone mineral density, treatment and follow- up. Results: The etiological factors involved hereditary, immunologic, iatrogenic (including operation, chemotherapy, radiotherapy, immunosuppressive therapy), infection, toxicant and psychological factors. The type of menstruation before amenorrhea was multiform. Seven cases have resumed menstruation for some time, even pregnancy after the diagnosis of SHA. About 72.7% of patients with SHA have low bone density. Conclusion: The obvious diversity of SHA is observed in etiology, course and clinical manifestation. It is possible for the patients with SHA to get pregnancy. The low bone density and other health problems of SHA patients should be paid attention to.
出处 《中国妇幼保健》 CAS 北大核心 2005年第17期2169-2172,共4页 Maternal and Child Health Care of China
关键词 继发性高促性腺激素闭经 异质性 骨密度 Secondary hypergonadotropic amenorrhea Heterogeneity Bone mineral density
  • 相关文献

参考文献10

  • 1郁琦,林守清,何方方,李包罗,林元,张涛,张颖.高促卵泡激素闭经患者低骨量的临床表现[J].中华妇产科杂志,1999,34(2):78-81. 被引量:2
  • 2林守清,林萍,姜玉新,魏杨,张颖,何方方,陈凤领,边旭明,谷春霞.绝经后卵巢和子宫萎缩及血雌二醇降低的观察[J].中华妇产科杂志,1997,32(9):524-527. 被引量:33
  • 3Speroff L, Glass RH, Kase HG (eds) . Clinical gynecologic endocrinology and infertility (Sixth ed. ): Amenorrhea. Baltimore, Lippincott Williams & Wilkins, 1999:421~446.
  • 4Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Ob Gyn, 1986, 67:604.
  • 5Machado erreira MC, Costa Lima MA, Boy RT et al. Premature ovarian failure and FMR1 premutation co-segregation in a large Brazilian family. Int J Mol Med, 2002, 10 (2): 231.
  • 6Nelson LM. Autoimmune ovarian failure: comparing the mouse model and the human disease. J Soc Gynecol Investig, 2001, 8 [ 1 Suppl]:S55.
  • 7Santoro N. Research on the mechanisms of premature ovarian failure. J Soc Gynecol Investig, 2001, 8 [ 1 Suppl]: S10.
  • 8Fernandes AM, Arruda Mde S, Bedone AJ. Twin gestation two years after the diagnosis of premature ovarian failure in a woman on hormone replacement therapy. A case report. J Reprod Med, 2002, 47 (6): 504.
  • 9Van Kasteren Y. Treatment concepts for premature ovarian failure. J Soc Gynecol Investig, 2001 Jan-Feb; 8 [l Suppl]: S58.
  • 10Elias AN; Pandian MR; Rojas FJ. Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls. Gynecol Obstet Investig, 1997, 43 (1): 47.

二级参考文献5

  • 1林守清 葛秦生 等.低剂量雌、孕激素对缓解更年期症状及降尿钙作用的研究[J].中华妇产科杂志,1990,25:198-201.
  • 2林守清 张涛 等.绝经后骨密度改变及其临床意义[J].生殖医学杂志,1993,2:17-22.
  • 3林守清,生殖医学杂志,1993年,2卷,19页
  • 4林守清,生殖医学杂志,1993年,2卷,17页
  • 5林守清,中华妇产科杂志,1990年,25卷,198页

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部